RND Group Supports Rheonix on COVID-19 Assay Release

Facebook
Twitter

RND Group is proud to support Rheonix’s COVID-19 release through implementing software changes requested by Rheonix, with plans to deliver completed software changes in less than 2 weeks, based on the urgency of releasing the COVID-19 test.

Rheonix, Inc., a leader in highly automated molecular diagnostics, announced this week that it is developing a coronavirus (COVID-19) test kit for use on its Encompass MDx© workstation.

RND Group is proud to support Rheonix’s COVID-19 release through implementing software changes requested by Rheonix, with plans to deliver completed software changes in less than 2 weeks, based on the urgency of releasing the COVID-19 test.

rheonix

More Information: Rheonix COVID-19 Press Release